GC63736
Samuraciclib hydrochloride hydrate
Samuraciclib (CT7001) hydrochloride hydrate is a potent, selective, ATP-competitive and orally active CDK7 inhibitor, with an IC50 of 41 nM· Samuraciclib hydrochloride hydrate displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2 (IC50 of 578 nM), CDK5 and CDK9, respectively· Samuraciclib hydrochloride hydrate inhibits the growth of breast cancer cell lines with GI50 values between 0·2-0·3 ?M· Samuraciclib hydrochloride hydrate has anti-tumor effects
ChemicalMW521.7FormulaC22H30N6O·(2·5HCl)·(2H2O)
- CAS number
- —
- Molecular weight
- 521.7
- Formula
- C22H30N6O·(2·5HCl)·(2H2O)
- Solubility
- DMSO ： 100 mg/mL (191·68 mM; Need ultrasonic)
- Catalogue number
- GC63736
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il